DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mylotarg (Gemtuzumab Ozogamicin) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mylotarg (Gemtuzumab Ozogamicin) where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mylotarg side effects in female

Reported by a physician from United States on 2012-06-04

Patient: female, weighing 64.9 kg (142.8 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Febrile Neutropenia, Disease Progression, Cardiac Failure, Injection Site Reaction, Sepsis, Pleural Effusion, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-11-04
    End date: 2011-11-12

Vidaza
    Dosage: 125 milligram/sq. meter
    Start date: 2011-11-04
    End date: 2011-11-10

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-10

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-10-04
    End date: 2011-10-12

Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-11

Mylotarg
    Dosage: 5.1 milligram
    Start date: 2011-11-07
    End date: 2011-11-11

Other drugs received by patient: Levothyroxine Sodium; Diphenhydramine HCL; Lipitor; Hydrocodone



Possible Mylotarg side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-16

Patient: 66 year old female, weighing 64.9 kg (142.8 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Cardiac Failure, Injection Site Reaction, Pleural Effusion, Febrile Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mylotarg
    Dosage: 3 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-11

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-11-04
    End date: 2011-11-12

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-10-04
    End date: 2011-10-10

Mylotarg
    End date: 2011-11-11

Zolinza
    Dosage: 400 milligram
    Administration route: Oral
    Start date: 2011-10-04
    End date: 2011-10-12

Vidaza
    Dosage: 75 milligram/sq. meter
    Start date: 2011-11-04

Other drugs received by patient: Hydrocodone; Lipitor; Diphenhydramine HCL; Levothyroxine Sodium



Possible Mylotarg side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-12

Patient: 55 year old male

Reactions: Pneumonia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2 for 7 days
    Indication: Acute Myeloid Leukaemia

Mylotarg
    Dosage: 3 mg/m2 on days 1, 4, and 7
    Indication: Acute Myeloid Leukaemia

Daunorubicin HCL
    Dosage: 60 mg/m2 for 3 days
    Indication: Acute Myeloid Leukaemia

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012